Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas

Autor: İrfan Cicin, Tahsin Özatlı, Esma Türkmen, Türkan Özturk, Melike Özçelik, Devrim Çabuk, Ayşe Gökdurnalı, Özlem Balvan, Yaşar Yıldız, Metin Şeker, Nuriye Özdemir, Burcu Yapar, Özgür Tanrıverdi, Yusuf Günaydin, Serkan Menekşe, Berna Öksüzoğlu, Asude Aksoy, Bülent Erdoğan, M. Bekir Hacıoglu, Erkan Arpaci, Alper Sevinç, Mehmet Atilla Uysal, Sinem İliaz

Publikováno v: Balkan Medical Journal, Vol 33, Iss 5, Pp 517-524 (2016)

Background: Prognostic factors and the standard treatment approach for gynaecological carcinosarcomas have not yet been clearly defined. Although carcinosarcomas are more aggressive than pure epithelial tumours, they are treated similarly. Serous/cle

Externí odkaz: https://doaj.org/article/a941accd41ad4cb09b80b59a161a3f2c

Real-life data on first-line Sunitinib and Pazopanib therapy in metastatic renal cell carcinoma patients: a single center experience.

Autor: Topal A; Trakya University School of Medicine, Department of Internal Medicine, Edirne, Turkey., Sayın S, Gokyer A, Kucukarda A, Kostek O, Bekir Hacıoglu M, Uzunoglu S, Erdogan B, Cicin I

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology [J BUON] 2021 Jul-Aug; Vol. 26 (4), pp. 1628-1634.

Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas.

Autor: Cicin İ; Department of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey., Özatlı T; Department of Medical Oncology, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Türkmen E; Department of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey., Özturk T; Department of Medical Oncology, Karadeniz Technical University School of Medicine, Trabzon, Turkey., Özçelik M; Department of Medical Oncology, Dr. Lütfi Kırdar Research and Training Hospital, İstanbul, Turkey., Çabuk D; Department of Medical Oncology, Kocaeli University School of Medicine, Kocaeli, Turkey., Gökdurnalı A; Department of Medical Oncology, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Balvan Ö; Department of Medical Oncology, Dr. Lütfi Kırdar Research and Training Hospital, İstanbul, Turkey., Yıldız Y; Department of Medical Oncology, Atatürk Research and Training Hospital, İzmir, Turkey., Şeker M; Department of Medical Oncology, Cumhuriyet University School of Medicine, Sivas, Turkey., Özdemir N; Department of Medical Oncology, Ankara Numune Research and Training Hospital, Ankara, Turkey., Yapar B; Department of Medical Oncology, Pamukkale University School of Medicine, Denizli, Turkey., Tanrıverdi Ö; Department of Medical Oncology, Muğla University School of Medicine, Muğla, Turkey., Günaydin Y; Department of Medical Oncology, Gazi University School of Medicine, Ankara, Turkey., Menekşe S; Department of Medical Oncology, Celal Bayar University School of Medicine, Manisa, Turkey., Öksüzoğlu B; Department of Medical Oncology, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Aksoy A; Department of Medical Oncology, İnönü University School of Medicine, Malatya, Turkey., Erdogan B; Department of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey., Bekir Hacıoglu M; Department of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey., Arpaci E; Department of Medical Oncology, Sakarya Research and Training Hospital, Sakarya, Turkey., Sevinç A; Department of Medical Oncology, Gaziantep University School of Medicine, Gaziantep, Turkey.

Publikováno v: Balkan medical journal [Balkan Med J] 2016 Sep; Vol. 33 (5), pp. 517-524. Date of Electronic Publication: 2016 Sep 01.